NVNO — enVVeno Medical Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for enVVeno Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -16.5 | -24.7 | -23.5 | -21.8 | -19.5 |
| Depreciation | |||||
| Non-Cash Items | 5.99 | 9.26 | 5.05 | 4.5 | 4.16 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.46 | -0.42 | -0.616 | 0.29 | -0.396 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -11.8 | -15.6 | -18.9 | -16.8 | -15.6 |
| Capital Expenditures | -0.368 | -0.115 | -0.033 | -0.037 | -0.005 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | -34.4 | -7.83 | 1.37 | 15.9 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.368 | -34.6 | -7.87 | 1.33 | 15.9 |
| Financing Cash Flow Items | — | 0 | 25.8 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 57.6 | 0 | 25.8 | 13.6 | 1.02 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 45.4 | -50.2 | -0.935 | -1.87 | 1.31 |